Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.55 |
| ▸ | ENPEP | Q07075 | 11/20 | 0.37 |
| ▸ | ANPEP | P15144 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL1067775 | 1.00 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL16194528 | 0.94 | — | — | |
| Cysteine SCHEMBL3396204 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL8378977 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL17473902 | 0.94 | — | — | |
| Cysteine SCHEMBL23903319 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL8501902 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL1072972 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL4864416 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5046068 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118216604-A | Preparation method of high-water-holding-capacity alcohol-method soybean protein concentrate | 丰益(上海)生物技术研发中心有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-20240141367-A1 | TARGETED GENE DEMETHYLATION IN PLANTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-02 | — | — | US | claimed |
| CN-113873986-B | Improving stability of zinc pyrithione in oxidizing environments such as scalp sebum fluids | 宝洁公司 | 2024-04-26 | — | — | CN | claimed |
| EP-3359138-B1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2024-04-24 | — | — | EP | claimed |
| WO-2023007088-A1 | FOOD SUPPLEMENT FOR COMBATING FEMALE AND MALE INFERTILITY | NURIBIOL (FR) | 2023-02-02 | — | — | WO | claimed |
| CN-113134387-B | Inner framework metal high-silicon beta molecular sieve catalyst and preparation method and application thereof | 陕西延长石油（集团）有限责任公司 | 2022-12-20 | — | — | CN | claimed |
| US-11471389-B2 | Enhanced stability of zinc pyrithione in oxidative environments, such as scalp sebaceous fluid | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-18 | — | — | US | claimed |
| EP-3801774-B1 | ENHANCED STABILITY OF ZINC PYRITHIONE IN OXIDATIVE ENVIRONMENTS, SUCH AS SCALP SEBACEOUS FLUID | PROCTER & GAMBLE (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113134387-A | Inner framework metal high-silicon beta molecular sieve catalyst and preparation method and application thereof | 陕西延长石油（集团）有限责任公司 | 2021-07-20 | — | — | CN | claimed |
| US-10966949-B2 | Dietary supplementation to achieve oxy-redox homeostasis and epigenetic stability | PARTHENOGEN SAGL (CH) | 2021-04-06 | — | — | US | claimed |
| WO-2007084818-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS TO ACHIEVE AND MAINTAIN A TARGETED AND STABLE COPPER STATUS AND PREVENT AND TREAT COPPER-RELATED CENTRAL NERVOUS SYSTEM DISEASES | PIPEX, INC. (US) | 2007-07-26 | — | — | WO | claimed |
| US-20040105894-A1 | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions | GUPTA SHYAM K (US) | 2004-06-03 | — | — | US | claimed |
| EP-0957890-B1 | HAIR TREATMENT COMPOSITION CONTAINING METAL-AMINOACID COMPLEX | UNILEVER PLC (GB) | 2002-02-13 | — | — | EP | claimed |
| US-6228353-B1 | HAIR RINSING COMPOSITION WITH AMINO ACIDS AND COMPLEXES, SURFACTANTS, POLYMERS | HELENE CURTIS, INC. | 2001-05-08 | — | — | US | claimed |
| US-6046146-A | DEGREASING AND DISINFECTING HARD SURFACES, MILDNESS TO SKIN | COLGATE PALMOLIVE COMPANY (US) | 2000-04-04 | — | — | US | claimed |
| CN-1241934-A | Hair treatment composition containing metal-amino acid complex | UNILEVER PLC (NL) | 2000-01-19 | — | — | CN | claimed |
| EP-0957890-A1 | HAIR TREATMENT COMPOSITION CONTAINING METAL-AMINOACID COMPLEX | UNILEVER PLC (GB) | 1999-11-24 | — | — | EP | claimed |
| US-5911978-A | METAL AMINO ACID COMPLEX, SURFACTANTS AND DEPOSITION AID FOR HAIR | HELENE CURTIS, INC. (US) | 1999-06-15 | — | — | US | claimed |
| WO-1998018432-A1 | HAIR TREATMENT COMPOSITION CONTAINING METAL-AMINOACID COMPLEX | UNILEVER PLC (GB) | 1998-05-07 | — | — | WO | claimed |
| WO-1989009777-A1 | METHODS AND MATERIALS RELATING TO DNA BINDING PROTEINS | ARCH DEVELOPMENT CORPORATION (US) | 1989-10-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11471389-B2 | Enhanced stability of zinc pyrithione in oxidative environments, such as scalp sebaceous fluid | HSD17B13, HSD17B7, HSD17B11 | PTGS1 2335/4885SLC7A11 313/4885ENPEP 3919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.